Skip to main content
. 2019 May 13;5(5):e01715. doi: 10.1016/j.heliyon.2019.e01715

Fig. 4.

Fig. 4

Simple linear regression analyses between fasting C-peptide and glucagon levels in patients with type 2 diabetes dividing into under treatment with or without insulin (a) and into under treatment with or without DPP-4 inhibitor or GLP-1 analog (b).